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petted and may be the underlying pathogenesis of occult 
renal insufficiency, as in the case presented. Furthermore, 
the onset of the syndrome may not be immediate and may 
be delayed following an invasive procedure. The proposed 
mechanism may be endothelial injury at the time of arte- 
rial manipulation (surgery) or catheter-related endothelial 
denudation that places the cholesterol-rich extracellular 
matrix in direct contract with the blood. This allows the 
turbulent blood to dislodge fragments from these now un- 
roofed ulcerated plaques. It may also be possible that em- 
bolism may occur spontaneously as a result of endothelial 
injury related to rheologic factors. 
Unfortunately, there are no ideal or effective treatment 
methods for the prevention or treatment of this syndrome. 
Anticoagulant therapy has been proposed as a possible 
preventive treatment, as the finding of superimposed 
thrombus is common. There are, however, no studies to 
support the use of anticoagulation and its potential adverse 
effects such as major hemorrhage in the elderly and the 
potential for plaque hemorrhage, as has been proposed in 
the past. If investigation of the aorta by TEE demonstrates 
significant atheromatosis with embolic potential, we rec- 
ommend the substitution of noninvasive vascular testing 
such as contrast computed tomography (CT) or magnetic 
resonance imaging (MRI) when feasible. The information 
obtained during transesophageal study may also be valu- 
able to the cardiovascular surgeon, who at the time of sur- 
gery may be able to perform endarterectomy, as has been 
suggested by Tunick et a1.5 In conclusion, the case pre- 
sented is the first report of a patient in which aortic ather- 
omas were documented in vivo and a subsequent tissue 
(renal) biopsy demonstrated arterial embolization of ath- 
erosclerotic debris. Thus TEE is useful for localizing aortic 
atheromatosis and may help identify patients who are at 
risk to develop cholesterol embolism associated with in- 
traaortic catheter placement. Furthermore, as suggested by 
Tunick et al.,7 protruding atheromas in the thoracic aorta 
may be an independent risk factor for systemic emboliza- 
tion. 
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Coronary arteriosclerosis of the cardiac allograft is a major 
cause of morbidity and mortality in late survivors of heart 
transplantation.1-3 Because transplant patients usually do 
not have angina pectoris, most centers perform coronary 
angiography annually to detect the onset or monitor pro- 
gression of allograft coronary artery disease. In addition to 
the typical diffuse luminal narrowing with distal vessel 
obliteration, cardiac transplant recipients with prolonged 
survival may have more sharply demarcated lesions.2, 3 
Percutaneous transluminal coronary angioplasty (PTCA) 
for focal proximal coronary stenoses has been performed to 
alleviate myocardial ischemia and prolong allograft func- 
tion.4* 5 Directional coronary atherectomy (DCA) in cardiac 
transplant recipients, however, has not been reported pre- 
viously. 
Patient A, a 37-year-old man with dilated cardiomyop- 
athy, received the heart of a 34-year-old female donor in 
January 1985. After transplantation, cyclosporine and 
prednisone were given for immunosuppression. There was 
one episode of acute rejection. The patient resumed smok- 
ing; in the posttransplant years the serum cholesterol level 
averaged 5.9 mmol/L, high-density lipoprotein cholesterol 
level 1.8 mmol/L, and serum triglyceride level 1.5 mmol/L. 
Results of routine annual coronary angiography showed 
development of diffuse luminal irregularities of the epicar- 
dial arteries without significant stenosis. On the fifth 
annual coronary angiogram, however, a focal eccentric le- 
sion was found in the middle segment of the left circumflex 
coronary artery. After ggmTc methoxyisobutyl isonitrile 
(MIBI) perfusion scintigrams had shown evidence of re- 
versible ischemia of the left ventricular posterior wall, the 
patient was referred to the catheterization laboratory for a 
percutaneous intervention. 
Patient B, a 28-year-old woman with postpartum cardi- 
omyopathy, received the heart of a 26-year-old male donor 
in April 1986. There were five episodes of acute rejection 
after transplantation, which were treated with pulsed doses 
of methylprednisolone and polyclonal and monoclonal an- 
ti-T cell antibodies. Because of ongoing rejection, azathi- 
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Fig. 1. Photomicrograph of atherectomy fragment from mid-left circumflex coronary artery of patient A 
showing moderate cellularity. Myofibroblasts are embedded in collagen bundles and extracellular matrix 
(hematoxylin-azofloxin stain; original magnification X120). 
Table I. Quantitative analysis of left circumflex (patient A) and left anterior descending (patient B) coronary 
segments before and after atherectomy and at follow-up 
Patient A Patient B 
Pre-DCA Post-DCA Follow-up Pre-DCA Post-DCA Follow-up 
MLD (mm) 1.8 3.0 2.6 0.8 2.4 1.8 
REF (mm) 3.9 3.7 3.7 2.4 3.0 2.5 
STEN (%) 54 19 30 67 20 28 
DCA, Directional coronary atherectomy; MLD, minimal luminal diameter; REF, reference diameter; STEN, diameter stenosis. 
oprine was added to the maintenance immunosuppressive 
therapy regimen which consisted of cyclosporine and 
prednisone. Hypertension was present, which was treated 
with vasodilators. The mean serum cholesterol level after 
transplantation was 6.0 mmol/L, and mean high-density 
lipoprotein cholesterol and triglyceride levels were 1.5 and 
1.8 mmol/L, respectively. On the third annual coronary 
angiogram, a focal 50% stenosis was detected in the left 
anterior descending coronary artery just distal to a large 
diagonal side branch. One year later this lesion had 
progressed to 80% diameter stenosis on visual interpreta- 
tion. After perfusion scintigraphy had shown reversible is- 
chemia of the anterior myocardium, a percutaneous inter- 
vention was scheduled. 
Because the geometry of the stenoses was considered to 
be ideal for atherectomy, that is, a localized eccentric lesion 
in a proximal to mid-coronary artery segment, DCA was 
performed in both patients with a device (Atherocath, De- 
vices for Vascular Intervention, Inc., Redwood City, Calif.) 
developed by Simpson’s group.‘j For anticoagulation and 
platelet inactivation, 10,000 IU of heparin and 250 mg of 
acetylsalicylic acid were given. To reduce vasomotor tone, 
intracoronary nitroglycerin was administered during the 
procedure and before the initial diagnostic and control an- 
giograms. An atherectomy device with a 6F profile was used 
in both patients, resulting in a decrease in the diameter of 
stenosis to <50 9% on visual assessment. No adjunctive bal- 
loon dilatation was required, and 6 hours after the proce- 
dure the sheath was removed. There were no complications 
related to the procedure, that is, ECG changes, myocardial 
enzyme elevations, or embolic or bleeding events, and the 
patients left the hospital in good condition the following 
day. ggmT~ MIBI perfusion scintigrams returned to normal 
in both patients, showing no evidence of myocardial 
ischemia after DCA. 
For histologic examination, fragments of retrieved arte- 
riosclerotic tissue were fixed in 10% buffered formalin, 
sectioned, and stained with hematoxylin-azofloxin and 
elastic van Gieson stain. Light microscopy of tissue col- 
lected from the left circumflex coronary artery of patient A 
showed moderate cellularity. Collagen bundles were sepa- 
rated by accumulations of homogeneous taining extracel- 
lular matrix (Fig. 1). Immunohistochemical staining with 
monoclonal antibodies specific for a-smooth muscle type 
actin was consistent with the myofibroblastic nature of the 
cells present. Results of histologic examination of retrieved 
tissue from the left anterior descending coronary artery of 
patient B showed mainly coarse collagen bundles with 
1666 Brief Communications 
June 1992 
American Heart Journal 
Fig. 2. Photomicrographs of arteriosclerotic tissue specimens collected from mid-left anterior descending 
coronary artery of patient B. A, Atherectomy fragment showing coarse collagen bundles with sporadic my- 
ofibroblasts. Black particles at periphery are considered to be abrasive dust from atherectomy device (he- 
matoxylin-azofloxin stain; original magnification x120). B, Collagenous tissue fragments with vasa vaso- 
rum (arrows) indicative of adventitia tissue (elastic van Gieson stain; original magnification x240). 
sporadic intermingled myofibroblasts (Fig. 2, A). Another 
atherectomy fragment from this lesion contained some in- 
tensely red-stained tissue incorporating vasa vasorum, 
which is indicative of adventitia (Fig. 2, B). 
Quantitative analysis was performed on the treated cor- 
onary segments with the use of the computer-assisted Car- 
diovascular Angiography Analysis System described pre- 
viously.7 In brief, an optically magnified portion of a 
selected 35 mm tine frame encompassing the segment of 
interest is converted into video format by means of a tine 
video converter. The contours of the vessel segment are 
detected automatically and corrected for pincushion dis- 
tortion caused by the image intensifier. The vessel diame- 
ter functions are determined in absolute millimeters by use 
of the guiding catheter as a scaling device. In the pre- and 
postatherectomy angiograms (Fig. 3) and follow-up angio- 
gram, the reference diameter and the minimal luminal di- 
ameter were measured and averaged from multiple views. 
The reference diameter is a computer estimation of the ex- 
pected normal diameter of the vessel at the site of obstruc- 
tion. To determine the minimal luminal diameter the ac- 
tual luminal contour is used. The percentage diameter 
stenosis can then be calculated. Results of quantitative 
coronary angiography are summarized in Table I. Results 
of follow-up angiography, 7 months (patient A) and 11 
months (patient B) after the intervention, revealed no sig- 
nificant restenosis on the basis of various angiographic cri- 
teria. 
Accelerated coronary artery disease of the cardiac al- 
lograft limits long-term survival (>l year) after heart 
transplantation. l-3 PTCA has been performed in cardiac 
transplant recipients with focal lesions in major epicardial 
coronary arteries or their branches.4, 5 Halle et a1.5 recently 
reported the results of a multicenter retrospective experi- 
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ence among 51 PTCA procedures for 95 lesions in 35 
patients 53 & 5 months after transplantation. Angio- 
graphic success, defined as 550% residual diameter steno- 
sis, was achieved in 88 of the 95 lesions (93%). The com- 
plication rate was comparable to that for routine PTCA in 
nontransplant patients. At follow-up 23 of the 35 patients 
(66 % ) were alive 13 -+ 3 months after PTCA. Major events 
including death, retransplantation, repeat PTCA, myocar- 
dial infarction, and progressive coronary disease occurred 
in 19 patients within 6 months after PTCA and in 14 pa- 
tients after 6 months. It was concluded that although 
PTCA may prolong cardiac allograft function, progression 
of coronary artery disease may be rapid requiring repeated 
interventions. 
In recent years, percutaneous DCAs 7 has been applied 
as an attractive alternative for the treatment of coronary 
artery disease including complex eccentric stenoses. With 
the advent of this new intervention a percutaneous “biop- 
sy technique” for collection of coronary arteriosclerotic 
tissue in selected heart transplant recipients has become 
available. Results of histopathologic examination of coro- 
nary arteries from cardiac allografts obtained at autopsy or 
retransplantation have shown a broad spectrum of abnor- 
malities ranging from concentric fibrous intimal thickening 
to focal arteriosclerotic plaques that bear a close resem- 
blance to spontaneous atherosclerosis.3 Fibrofatty athero- 
matous plaques and so-called intermediate lesions are fre- 
quently found in cardiac allografts with survival times of 3 
to 5 years or longer.3 In a recently published study by 
Johnson et a1.,3 histopathologic features were correlated 
with the angiographic appearance of transplant coronary 
artery disease. It was demonstrated from the hearts of 10 
cardiac transplant recipients who died or underwent re- 
transplantation within 2 months of coronary angiography 
that two thirds of discrete proximal stenoses corresponded 
to intermediate or atheromatous disease. Our findings 
seem to be in agreement with these observations; geometry 
and histology of the resected lesions in the present patients 
resembled native coronary artery disease. 
In previous studies from other groups and ours, it has 
been shown that DCA is a relatively safe procedure.6pg Our 
limited experience in two transplant patients indicates that 
DCA can be applied safely and effectively for discrete cor- 
onary lesions in allograft arteriosclerosis. The intervention 
was uncomplicated and successful in both patients as 
judged by angiography and control perfusion scintigraphy. 
Angiographic success, as confirmed by quantitative analy- 
sis, was maintained after 7 and 11 months of follow-up, re- 
spectively. This favorable long-term outcome after DCA is 
the result of actual removal of excess arteriosclerotic tissue. 
In matched patient populations with native coronary arte- 
riosclerosis, however, DCA has been shown to have an in- 
cidence of restenosis comparable to that of PTCA,’ despite 
a substantially better initial result.6 g DCA has the advan- 
tage in that it enables histologic analysis of removed tissue 
acting as a biopsy technique. In one histologic studyi’ a low 
smooth muscle cell density in arteriosclerotic tissue excised 
by DCA from native coronary arteries was associated with 
an eight times lower restenosis rate after 6 months than le- 
Fig. 3. Edge contour analysis of obstruction in middle 
segment of left circumflex coronary artery of patient A, 
filmed from caudal view before (A) and after(B) directional 
atherectomy. White area is measure for “arteriosclerotic 
plaque” and is derived from actual luminal contour and 
reconstructed reference contour. Diameter function and 
reference curves are shown at bottom. Minimal luminal di- 
ameter (uerticle line) increased from 2.2 mm to 3.2 mm, 
corresponding to decrease in diameter of stenosis from 
51% to 28% and area of stenosis from 76% to 48% in this 
projection. 
sions with moderate cell density. The favorable long-term 
outcome after DCA in our two transplant patients, how- 
ever, was not related to the moderate (patient A) and low 
cellularity (patient B) in retrieved arteriosclerotic tissue. 
Further studies are required to demonstrate whether DCA 
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of focal coronary lesions in cardiac transplant patients is 
followed by a lower restenosis rate as after PTCA. 
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Self-limited acute pericarditis as initial 
manifestation of primary cardiac tumor 
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The etiologic diagnosis of acute pericarditis is difficult and 
often has a low yield. Actually, the diagnosis of idiopathic 
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pericarditis is accepted on the basis of excluding other 
specific causes.’ There are no clinical features leading to 
specific diagnosis, but it is generally accepted that a short, 
self-limited clinical course favors a viral or idiopathic diag- 
nosis and, by contrast, a prolonged, progressive course with 
clinical deterioration suggests a specific etiology of peri- 
carditis, including malignancy.’ On the other hand, a 
relapsing course with an initial onset followed by remission 
and a second outbreak is considered very suggestive of the 
benign forms of pericarditis (viral, idiopathic, autoim- 
mune). A high degree of clinical alertness is needed for di- 
agnosing cardiac tumors, as these disorders are uncommon” 
and are associated with protean manifestations. When the 
tumor involves t.he pericardium, pericardial effusion is the 
most common finding.4 This effusion is usually hemor- 
rhagic and is often associated with cardiac tamponade. In- 
deed, onset as acute pericarditis is very rare.5,6 We report 
three cases of cardiac neoplasms that initially were diag- 
nosed as acute pericarditis because they had a short, self- 
limited course but that, after a period of 3 weeks to 1 year, 
developed overt clinical manifestations of cardiac tumors. 
Case No. 1. A 59-year-old woman with a 3-month history 
of constitutional symptoms and a 5 kg weight loss was ad- 
mitted to our institution after 3 weeks of fever, pericardial 
pain, and progressive dyspnea. An echocardiogram (Fig. 1, 
A) disclosed a large pericardial effusion. Overt cardiac 
tamponade developed rapidly. Pericardiocentesis yielded 
hemorrhagic fluid (packed red blood cells 27 5,) whose cy- 
tology turned out to be nonspecific. Pericardial biopsy 
showed a fibrinous pericarditis without malignant cells. 
Thereafter the patient improved as fever, pericardial pain, 
Fig. 1. Case No. 1. A, On admission, an M-mode echocar- 
diogram showed a wide anterior and posterior free space 
corresponding to pericardial effusion (PE). B, After 3 
weeks, pericardial effusion had nearly disappeared and the 
recording just demonstrated a thickened pericar, ’ -’ 
Left ventricle; RV, right ventricle. 
